James J. Ellinger, Ph.D. - Publications

Affiliations: 
2012 Biochemistry-ALS University of Wisconsin, Madison, Madison, WI 
Area:
NMR spectroscopy and its biological applications

10/156 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Murdock L, Burke T, Coumoundouros C, Culham DE, Deutch CE, Ellinger J, Kerr CH, Plater SM, To E, Wright G, Wood JM. Analysis of strains lacking known osmolyte accumulation mechanisms reveals contributions of osmolytes and transporters to protection against abiotic stress. Applied and Environmental Microbiology. 80: 5366-78. PMID 24951793 DOI: 10.1128/AEM.01138-14  0.8
2013 Ellinger JJ, Chylla RA, Ulrich EL, Markley JL. Databases and Software for NMR-Based Metabolomics. Current Metabolomics. 1. PMID 24260723 DOI: 10.2174/2213235X11301010028  0.92
2013 Clos LJ, Jofre MF, Ellinger JJ, Westler WM, Markley JL. NMRbot: Python scripts enable high-throughput data collection on current Bruker BioSpin NMR spectrometers. Metabolomics : Official Journal of the Metabolomic Society. 9: 558-563. PMID 23678341 DOI: 10.1007/s11306-012-0490-9  0.8
2012 Chae YK, Kim SH, Ellinger JJ, Markley JL. Tracing Metabolite Footsteps of Escherichia coli Along the Time Course of Recombinant Protein Expression by Two-Dimensional NMR Spectroscopy. Bulletin of the Korean Chemical Society. 33: 4041-4046. PMID 23794775 DOI: 10.5012/bkcs.2012.33.12.4041  0.8
2012 Schwalbach MS, Keating DH, Tremaine M, Marner WD, Zhang Y, Bothfeld W, Higbee A, Grass JA, Cotten C, Reed JL, da Costa Sousa L, Jin M, Balan V, Ellinger J, Dale B, et al. Complex physiology and compound stress responses during fermentation of alkali-pretreated corn stover hydrolysate by an Escherichia coli ethanologen. Applied and Environmental Microbiology. 78: 3442-57. PMID 22389370 DOI: 10.1128/AEM.07329-11  0.8
2012 Ellinger JJ, Miller DC, Lewis IA, Markley JL. Semiautomated device for batch extraction of metabolites from tissue samples. Analytical Chemistry. 84: 1809-12. PMID 22292466 DOI: 10.1021/ac203390v  0.8
2011 Hu K, Ellinger JJ, Chylla RA, Markley JL. Measurement of absolute concentrations of individual compounds in metabolite mixtures by gradient-selective time-zero 1H-13C HSQC with two concentration references and fast maximum likelihood reconstruction analysis. Analytical Chemistry. 83: 9352-60. PMID 22029275 DOI: 10.1021/ac201948f  0.8
2011 Chylla RA, Hu K, Ellinger JJ, Markley JL. Deconvolution of two-dimensional NMR spectra by fast maximum likelihood reconstruction: application to quantitative metabolomics. Analytical Chemistry. 83: 4871-80. PMID 21526800 DOI: 10.1021/ac200536b  0.8
2011 Ellinger JJ, Lewis IA, Markley JL. Role of aminotransferases in glutamate metabolism of human erythrocytes. Journal of Biomolecular Nmr. 49: 221-9. PMID 21380856 DOI: 10.1007/s10858-011-9481-9  0.8
2011 Hallows WC, Yu W, Smith BC, Devries MK, Devires MK, Ellinger JJ, Someya S, Shortreed MR, Prolla T, Markley JL, Smith LM, Zhao S, Guan KL, Denu JM. Sirt3 promotes the urea cycle and fatty acid oxidation during dietary restriction. Molecular Cell. 41: 139-49. PMID 21255725 DOI: 10.1016/j.molcel.2011.01.002  0.8
Low-probability matches
2015 Li D, Ellinger J, Liu Z, Wu Z, Zhang Z. Mixed signal detection and symbol rate estimation based on spectral coherent features Proceedings - Ieee Military Communications Conference Milcom. 2015: 263-268. DOI: 10.1109/MILCOM.2015.7357453  0.08
2013 Ellinger J, Wu Z. Cost function analysis for FD-MC-CDMA blind frequency offset estimation in high speed aerial communication Proceedings - Ieee Military Communications Conference Milcom. 797-802. DOI: 10.1109/MILCOM.2013.141  0.08
2013 Li X, Han Q, Ellinger J, Zhang J, Wu Z. General total inter-carrier interference cancellation for OFDM high speed aerial vehicle communication Ieee International Conference On Communications. 4698-4702. DOI: 10.1109/ICC.2013.6655314  0.08
2012 Oll M, Baumann C, Behbahani TE, von Ruecker A, Müller SC, Ellinger J. Identification of prostaglandin receptors in human ureters. Bmc Urology. 12: 35. PMID 23227994 DOI: 10.1186/1471-2490-12-35  0.04
2012 Ellinger J, Depoy R, Sanderson J, Huang K, Wu Z. Blind frequency offset estimation and intercarrier interference cancelation for FD-MC-CDMA systems in aerial vehicle communication Proceedings - Ieee Military Communications Conference Milcom. DOI: 10.1109/MILCOM.2012.6415840  0.08
2016 Schrödter S, Braun M, Syring I, Klümper N, Deng M, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma Molecular Cancer. 15. DOI: 10.1186/s12943-016-0495-5  0.04
2015 Deng M, Blondeau JJ, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of novel differentially expressed lncRNA and mRNA transcripts in clear cell renal cell carcinoma by expression profiling. Genomics Data. 5: 173-5. PMID 26484251 DOI: 10.1016/j.gdata.2015.06.016  0.04
2015 Klümper N, Syring I, Offermann A, Shaikhibrahim Z, Vogel W, Müller SC, Ellinger J, Strauß A, Radzun HJ, Ströbel P, Brägelmann J, Perner S, Bremmer F. Differential expression of Mediator complex subunit MED15 in testicular germ cell tumors. Diagnostic Pathology. 10: 165. PMID 26377566 DOI: 10.1186/s13000-015-0398-6  0.04
2015 Latz S, Umbach T, Goltz D, Kristiansen G, Müller SC, Ellinger J. Cytoplasmatic and Nuclear YAP1 and pYAP1 Staining in Urothelial Bladder Cancer. Urologia Internationalis. PMID 26287745 DOI: 10.1159/000438868  0.04
2015 Aziz A, Gierth M, Rink M, Schmid M, Chun FK, Dahlem R, Roghmann F, Palisaar RJ, Noldus J, Ellinger J, Müller SC, Pycha A, Martini T, Bolenz C, Moritz R, et al. Optimizing outcome reporting after radical cystectomy for organ-confined urothelial carcinoma of the bladder using oncological trifecta and pentafecta. World Journal of Urology. PMID 25947885 DOI: 10.1007/s00345-015-1572-x  0.04
2015 Ellinger J, Müller SC, Dietrich D. Epigenetic biomarkers in the blood of patients with urological malignancies. Expert Review of Molecular Diagnostics. 15: 505-16. PMID 25719388 DOI: 10.1586/14737159.2015.1019477  0.04
2015 Blondeau JJ, Deng M, Syring I, Schrödter S, Schmidt D, Perner S, Müller SC, Ellinger J. Identification of novel long non-coding RNAs in clear cell renal cell carcinoma. Clinical Epigenetics. 7: 10. PMID 25685243 DOI: 10.1186/s13148-015-0047-7  0.04
2015 Kohls K, Schmidt D, Holdenrieder S, Müller SC, Ellinger J. [Detection of cell-free lncRNA in serum of cancer patients]. Der Urologe. Ausg. A. 54: 819-25. PMID 25312755 DOI: 10.1007/s00120-014-3655-5  0.04
2015 Schmid M, Rink M, Traumann M, Bastian PJ, Bartsch G, Ellinger J, Grimm MO, Hadaschik B, Haferkamp A, Hakenberg OW, Aziz A, Hartmann F, Herrmann E, Hohenfellner M, Janetschek G, et al. Evidence from the 'PROspective MulticEnTer RadIcal Cystectomy Series 2011 (PROMETRICS 2011)' study: how are preoperative patient characteristics associated with urinary diversion type after radical cystectomy for bladder cancer? Annals of Surgical Oncology. 22: 1032-42. PMID 25164037 DOI: 10.1245/s10434-014-4029-3  0.04
2015 Syring I, Bartels J, Holdenrieder S, Kristiansen G, Müller SC, Ellinger J. Circulating serum miRNA (miR-367-3p, miR-371a-3p, miR-372-3p and miR-373-3p) as biomarkers in patients with testicular germ cell cancer. The Journal of Urology. 193: 331-7. PMID 25046619 DOI: 10.1016/j.juro.2014.07.010  0.04
2015 Fischer N, Göke F, Kahl P, Splittstößer V, Lankat-Buttgereit B, Müller SC, Ellinger J. Programmed cell death protein 4 -expression in urologic tumors Open Pain Journal. 7: 7-11. DOI: 10.2174/1876822901407010007  0.04
2014 Stein J, Majores M, Rohde M, Lim S, Schneider S, Krappe E, Ellinger J, Dietel M, Stephan C, Jung K, Perner S, Kristiansen G, Kirfel J. KDM5C is overexpressed in prostate cancer and is a prognostic marker for prostate-specific antigen-relapse following radical prostatectomy. The American Journal of Pathology. 184: 2430-7. PMID 25016185 DOI: 10.1016/j.ajpath.2014.05.022  0.04
2014 Dietrich D, Meller S, Uhl B, Ralla B, Stephan C, Jung K, Ellinger J, Kristiansen G. Nucleic acid-based tissue biomarkers of urologic malignancies. Critical Reviews in Clinical Laboratory Sciences. 51: 173-99. PMID 24878394 DOI: 10.3109/10408363.2014.906130  0.04
2014 Ellinger J, Muller SC. MicroRNAs: a novel non-invasive biomarker for patients with urological malignancies. Current Pharmaceutical Biotechnology. 15: 486-91. PMID 24846060  0.04
2014 Ellinger J, Bachmann A, Göke F, Behbahani TE, Baumann C, Heukamp LC, Rogenhofer S, Müller SC. Alterations of global histone H3K9 and H3K27 methylation levels in bladder cancer. Urologia Internationalis. 93: 113-8. PMID 24556868 DOI: 10.1159/000355467  0.04
2014 Westermann AM, Schmidt D, Holdenrieder S, Moritz R, Semjonow A, Schmidt M, Kristiansen G, Müller SC, Ellinger J. Serum microRNAs as biomarkers in patients undergoing prostate biopsy: results from a prospective multi-center study. Anticancer Research. 34: 665-9. PMID 24510997  0.04
2014 Weiss VL, Braun M, Perner S, Harz A, Vorreuther R, Kristiansen G, Müller SC, Ellinger J. Prognostic significance of venous tumour thrombus consistency in patients with renal cell carcinoma (RCC). Bju International. 113: 209-17. PMID 24053185 DOI: 10.1111/bju.12322  0.04
2014 Latz S, Achterberg M, Ellinger J, Engels T, Hauser S, Rogenhofer S, Müller SC, Fechner G. Diagnostic meaning of urodynamic studies in pouch incontinence: results of a small series. Urologia Internationalis. 92: 237-41. PMID 24051578 DOI: 10.1159/000353417  0.04
2014 Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, et al. Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: An external validation World Journal of Urology. 32: 365-371. PMID 23736527 DOI: 10.1007/s00345-013-1105-4  0.04
2014 Scheffer AR, Holdenrieder S, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? World Journal of Urology. 32: 353-8. PMID 23266581 DOI: 10.1007/s00345-012-1010-2  0.04
2013 Hauser S, Zahalka T, Fechner G, Müller SC, Ellinger J. Serum DNA hypermethylation in patients with kidney cancer: results of a prospective study. Anticancer Research. 33: 4651-6. PMID 24123044  0.04
2013 Schiffgen M, Schmidt DH, von Rücker A, Müller SC, Ellinger J. Epigenetic regulation of microRNA expression in renal cell carcinoma. Biochemical and Biophysical Research Communications. 436: 79-84. PMID 23707942 DOI: 10.1016/j.bbrc.2013.05.061  0.04
2013 Hauser S, Kogej M, Fechner G, VON Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J. Serum DNA hypermethylation in patients with bladder cancer: results of a prospective multicenter study. Anticancer Research. 33: 779-84. PMID 23482744  0.04
2013 Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, et al. Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks European Journal of Surgical Oncology. 39: 372-379. PMID 23465180 DOI: 10.1016/j.ejso.2013.02.009  0.04
2013 Latz S, Ellinger J, Goltz D, Marx C, Leuschner I, Müller SC, Fechner G. Spindle cell rhabdomyosarcoma of the prostate. International Journal of Urology : Official Journal of the Japanese Urological Association. 20: 935-7. PMID 23320845 DOI: 10.1111/iju.12082  0.04
2013 Rogenhofer S, Miersch H, Göke F, Kahl P, Wieland WF, Hofstädter F, Kristiansen G, von Ruecker A, Müller SC, Ellinger J. Histone methylation defines an epigenetic entity in penile squamous cell carcinoma. The Journal of Urology. 189: 1117-22. PMID 22999995 DOI: 10.1016/j.juro.2012.08.221  0.04
2013 May M, Bastian PJ, Brookman-May S, Fritsche HM, Tilki D, Otto W, Bolenz C, Gilfrich C, Trojan L, Herrmann E, Moritz R, Tiemann A, Müller SC, Ellinger J, Buchner A, et al. Gender-specific differences in cancer-specific survival after radical cystectomy for patients with urothelial carcinoma of the urinary bladder in pathologic tumor stage T4a Urologic Oncology: Seminars and Original Investigations. 31: 1141-1147. PMID 22056404 DOI: 10.1016/j.urolonc.2011.09.011  0.04
2013 Latz S, Müller SC, Ellinger J. Diagnostic und therapeutic value of cell-free circulating DNA as a non-invasive biomarker in patients with prostate cancer Current Cancer Therapy Reviews. 9: 258-264. DOI: 10.2174/157339470904140418094329  0.04
2013 Moritz R, Ellinger J, Nuhn P, Haese A, Müller SC, Graefen M, Schlomm T, Bastian PJ. DNA hypermethylation as a predictor of PSA recurrence in patients with low- and intermediate-grade prostate cancer Anticancer Research. 33: 5249-5254.  0.04
2012 Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, et al. Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder. Gender Medicine. 9: 481-489. PMID 23217567 DOI: 10.1016/j.genm.2012.11.001  0.04
2012 Scheid L, Ellinger S, Alteheld B, Herholz H, Ellinger J, Henn T, Helfrich HP, Stehle P. Kinetics of L-theanine uptake and metabolism in healthy participants are comparable after ingestion of L-theanine via capsules and green tea Journal of Nutrition. 142: 2091-2096. PMID 23096008 DOI: 10.3945/jn.112.166371  0.04
2012 Ellinger S, Gordon A, Kürten M, Jungfer E, Zimmermann BF, Zur B, Ellinger J, Marx F, Stehle P. Bolus consumption of a specifically designed fruit juice rich in anthocyanins and ascorbic acid did not influence markers of antioxidative defense in healthy humans. Journal of Agricultural and Food Chemistry. 60: 11292-300. PMID 23072538 DOI: 10.1021/jf300719t  0.04
2012 Rogenhofer S, Ellinger J, Kahl P, Stoehr C, Hartmann A, Engehausen D, Wieland WF, Müller SC, Hofstädter F, Walter B. Enhanced expression of peroxisome proliferate-activated receptor gamma (PPAR-γ) in advanced prostate cancer. Anticancer Research. 32: 3479-83. PMID 22843934  0.04
2012 Hauser S, Kogej M, Fechner G, Von Ruecker A, Bastian PJ, Von Pezold J, Vorreuther R, Lümmen G, Müller SC, Ellinger J. Cell-free serum DNA in patients with bladder cancer: results of a prospective multicenter study. Anticancer Research. 32: 3119-24. PMID 22843882  0.04
2012 Sanders I, Holdenrieder S, Walgenbach-Brünagel G, von Ruecker A, Kristiansen G, Müller SC, Ellinger J. Evaluation of reference genes for the analysis of serum miRNA in patients with prostate cancer, bladder cancer and renal cell carcinoma International Journal of Urology. 19: 1017-1025. PMID 22788411 DOI: 10.1111/j.1442-2042.2012.03082.x  0.04
2012 Hauser S, Rogenhofer S, Ellinger J, Strunk T, Müller SC, Fechner G. Thulium laser (Revolix) vapoenucleation of the prostate is a safe procedure in patients with an increased risk of hemorrhage. Urologia Internationalis. 88: 390-4. PMID 22627127 DOI: 10.1159/000336874  0.04
2012 Hauser S, Wulfken LM, Holdenrieder S, Moritz R, Ohlmann CH, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. Analysis of serum microRNAs (miR-26a-2*, miR-191, miR-337-3p and miR-378) as potential biomarkers in renal cell carcinoma. Cancer Epidemiology. 36: 391-4. PMID 22542158 DOI: 10.1016/j.canep.2012.04.001  0.04
2012 Göke F, Franzen A, Menon R, Goltz D, Kirsten R, Boehm D, Vogel W, Gok̈e A, Scheble V, Ellinger J, Gerigk U, Fend F, Wagner P, Schroeck A, Perner S. Rationale for treatment of metastatic squamous cell carcinoma of the lung using fibroblast growth factor receptor inhibitors Chest. 142: 1020-1026. PMID 22499828 DOI: 10.1378/chest.11-2943  0.04
2012 Nuhn P, May M, Fritsche HM, Buchner A, Brookman-May S, Bolenz C, Moritz R, Herrmann E, Burger M, Höfner T, Ellinger J, Tilki D, Roigas J, Zacharias M, Trojan L, et al. External validation of disease-free survival at 2 or 3 years as a surrogate and new primary endpoint for patients undergoing radical cystectomy for urothelial carcinoma of the bladder. European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 38: 637-42. PMID 22459902 DOI: 10.1016/j.ejso.2012.02.187  0.04
2012 Behbahani TE, Kahl P, von der Gathen J, Heukamp LC, Baumann C, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S, Ellinger J. Alterations of global histone H4K20 methylation during prostate carcinogenesis. Bmc Urology. 12: 5. PMID 22413846 DOI: 10.1186/1471-2490-12-5  0.04
2012 Rogenhofer S, Kahl P, Holzapfel S, VON Ruecker A, Mueller SC, Ellinger J. Decreased levels of histone H3K9me1 indicate poor prognosis in patients with renal cell carcinoma. Anticancer Research. 32: 879-86. PMID 22399607  0.04
2012 May M, Bastian PJ, Brookman-May S, Fritsche HM, Bolenz C, Gilfrich C, Otto W, Trojan L, Herrmann E, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Wieland WF, et al. External validation of a risk model to predict recurrence-free survival after radical cystectomy in patients with pathological tumor stage T3N0 urothelial carcinoma of the bladder. The Journal of Urology. 187: 1210-4. PMID 22335861 DOI: 10.1016/j.juro.2011.11.104  0.04
2012 Ellinger J, Kahl P, von der Gathen J, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Bastian PJ, von Ruecker A, Müller SC, Rogenhofer S. Global histone H3K27 methylation levels are different in localized and metastatic prostate cancer. Cancer Investigation. 30: 92-7. PMID 22149091 DOI: 10.3109/07357907.2011.636117  0.04
2012 Fischer N, Göke F, Splittstösser V, Lankat-Buttgereit B, Müller SC, Ellinger J. Expression of programmed cell death protein 4 (PDCD4) and miR-21 in urothelial carcinoma. Biochemical and Biophysical Research Communications. 417: 29-34. PMID 22133680 DOI: 10.1016/j.bbrc.2011.11.035  0.04
2012 Behbahani TE, Ellinger J, Caratozzolo DG, Müller SC. Pathological outcomes of men eligible for active surveillance after undergoing radical prostatectomy: are results predictable? Clinical Genitourinary Cancer. 10: 32-6. PMID 22104434 DOI: 10.1016/j.clgc.2011.09.004  0.04
2012 Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Perner S, Wernert N. The peripheral zone of the prostate is more prone to tumor development than the transitional zone: Is the ETS family the key? Molecular Medicine Reports. 5: 313-316. PMID 22038307 DOI: 10.3892/mmr.2011.647  0.04
2012 Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buettner R, Wernert N. Genes differentially expressed in the peripheral zone compared to the transitional zone of the normal human prostate and their potential regulation by ETS factors Molecular Medicine Reports. 5: 32-36. PMID 21993862 DOI: 10.3892/mmr.2011.628  0.04
2012 Behbahani TE, Thierse C, Baumann C, Holl D, Bastian PJ, von Ruecker A, Müller SC, Ellinger J, Hauser S. Tyrosine kinase expression profile in clear cell renal cell carcinoma. World Journal of Urology. 30: 559-65. PMID 21969129 DOI: 10.1007/s00345-011-0767-z  0.04
2012 Rogenhofer S, Kahl P, Mertens C, Hauser S, Hartmann W, Büttner R, Müller SC, von Ruecker A, Ellinger J. Global histone H3 lysine 27 (H3K27) methylation levels and their prognostic relevance in renal cell carcinoma. Bju International. 109: 459-65. PMID 21810159 DOI: 10.1111/j.1464-410X.2011.10278.x  0.04
2012 Ellinger J, Müller DC, Müller SC, Hauser S, Heukamp LC, von Ruecker A, Bastian PJ, Walgenbach-Brunagel G. Circulating mitochondrial DNA in serum: a universal diagnostic biomarker for patients with urological malignancies. Urologic Oncology. 30: 509-15. PMID 20870429 DOI: 10.1016/j.urolonc.2010.03.004  0.04
2011 Wulfken LM, Moritz R, Ohlmann C, Holdenrieder S, Jung V, Becker F, Herrmann E, Walgenbach-Brünagel G, von Ruecker A, Müller SC, Ellinger J. MicroRNAs in renal cell carcinoma: diagnostic implications of serum miR-1233 levels. Plos One. 6: e25787. PMID 21984948 DOI: 10.1371/journal.pone.0025787  0.04
2011 Hauptstock V, Kuriakose S, Schmidt D, Düster R, Müller SC, von Ruecker A, Ellinger J. Glutathione-S-transferase pi 1(GSTP1) gene silencing in prostate cancer cells is reversed by the histone deacetylase inhibitor depsipeptide. Biochemical and Biophysical Research Communications. 412: 606-11. PMID 21855532 DOI: 10.1016/j.bbrc.2011.08.007  0.04
2011 Shaikhibrahim Z, Lindstrot A, Ellinger J, Rogenhofer S, Buetner R, Wernert N. Identification of immunity-related genes in prostate cancer and potential role of the ETS family of transcription factors in their regulation International Journal of Molecular Medicine. 28: 799-807. PMID 21833467 DOI: 10.3892/ijmm.2011.771  0.04
2011 May M, Bastian PJ, Burger M, Bolenz C, Trojan L, Herrmann E, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, Otto W, Höfner T, Hohenfellner M, et al. Multicenter evaluation of the prognostic value of pT0 stage after radical cystectomy due to urothelial carcinoma of the bladder. Bju International. 108: E278-83. PMID 21699644 DOI: 10.1111/j.1464-410X.2011.10189.x  0.04
2011 Schneider AC, Heukamp LC, Rogenhofer S, Fechner G, Bastian PJ, von Ruecker A, Müller SC, Ellinger J. Global histone H4K20 trimethylation predicts cancer-specific survival in patients with muscle-invasive bladder cancer. Bju International. 108: E290-6. PMID 21627749 DOI: 10.1111/j.1464-410X.2011.10203.x  0.04
2011 Mahn R, Heukamp LC, Rogenhofer S, von Ruecker A, Müller SC, Ellinger J. Circulating microRNAs (miRNA) in serum of patients with prostate cancer. Urology. 77: 1265.e9-16. PMID 21539977 DOI: 10.1016/j.urology.2011.01.020  0.04
2011 May M, Bastian PJ, Brookman-May S, Burger M, Bolenz C, Trojan L, Michel MS, Herrmann E, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, et al. Pathological upstaging detected in radical cystectomy procedures is associated with a significantly worse tumour-specific survival rate for patients with clinical T1 urothelial carcinoma of the urinary bladder. Scandinavian Journal of Urology and Nephrology. 45: 251-7. PMID 21388337 DOI: 10.3109/00365599.2011.562235  0.04
2011 May M, Burger M, Brookman-May S, Otto W, Peter J, Rud O, Fritsche HM, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Moritz R, Tiemann A, Müller SC, ... Ellinger J, et al. [Validation of pre-cystectomy nomograms for the prediction of locally advanced urothelial bladder cancer in a multicentre study: are we able to adequately predict locally advanced tumour stages before surgery?]. Der Urologe. Ausg. A. 50: 706-13. PMID 21340594 DOI: 10.1007/s00120-011-2506-x  0.04
2011 May M, Fritsche HM, Gilfrich C, Brookman-May S, Burger M, Otto W, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, et al. [Influence of older age on survival after radical cystectomy due to urothelial carcinoma of the bladder: survival analysis of a German multi-centre study after curative treatment of urothelial carcinoma of the bladder]. Der Urologe. Ausg. A. 50: 821-9. PMID 21340593 DOI: 10.1007/s00120-011-2507-9  0.04
2011 May M, Herrmann E, Bolenz C, Tiemann A, Brookman-May S, Fritsche HM, Burger M, Buchner A, Gratzke C, Wülfing C, Trojan L, Ellinger J, Tilki D, Gilfrich C, Höfner T, et al. Lymph node density affects cancer-specific survival in patients with lymph node-positive urothelial bladder cancer following radical cystectomy. European Urology. 59: 712-8. PMID 21296488 DOI: 10.1016/j.eururo.2011.01.030  0.04
2011 May M, Herrmann E, Bolenz C, Brookman-May S, Tiemann A, Moritz R, Fritsche HM, Burger M, Trojan L, Michel MS, Wülfing C, Müller SC, Ellinger J, Buchner A, Stief CG, et al. Association between the number of dissected lymph nodes during pelvic lymphadenectomy and cancer-specific survival in patients with lymph node-negative urothelial carcinoma of the bladder undergoing radical cystectomy. Annals of Surgical Oncology. 18: 2018-25. PMID 21246405 DOI: 10.1245/s10434-010-1538-6  0.04
2011 Dewald O, Duerr GD, Elhafi N, Bostani T, Ellinger J, Swieny L, Kolobara E, Welz A. Comparison of myocardial remodeling between cryoinfarction and reperfused infarction in mice Journal of Biomedicine and Biotechnology. 2011. PMID 21151617 DOI: 10.1155/2011/961298  0.04
2011 Ellinger J, Holl D, Nuhn P, Kahl P, Haseke N, Staehler M, Siegert S, Hauser S, Stief CG, Müller SC, Bastian PJ. DNA hypermethylation in papillary renal cell carcinoma. Bju International. 107: 664-9. PMID 20553257 DOI: 10.1111/j.1464-410X.2010.09468.x  0.04
2011 Ellinger J, Müller SC, Stadler TC, Jung A, von Ruecker A, Bastian PJ. The role of cell-free circulating DNA in the diagnosis and prognosis of prostate cancer. Urologic Oncology. 29: 124-9. PMID 19762255 DOI: 10.1016/j.urolonc.2009.05.010  0.04
2010 Stadler TC, Jung A, Schlenker B, Nuhn P, Ellinger J, Kirchner T, Stief CG, Bastian PJ. [Pyrosequencing in uro-oncology: applications in prostate cancer]. Der Urologe. Ausg. A. 49: 1356-64. PMID 20945059 DOI: 10.1007/s00120-010-2426-1  0.04
2010 May M, Fritsche HM, Brookman-May S, Burger M, Bolenz C, Trojan L, Herrmann E, Michel MS, Wülfing C, Tiemann A, Müller SC, Ellinger J, Buchner A, Stief CG, Tilki D, et al. [Patients with bladder cancer in clinical stage T2 : survival benefit of downstaging in comparison to patients with confirmed muscle invasion in cystectomy specimens]. Der Urologe. Ausg. A. 49: 1508-15. PMID 20922515 DOI: 10.1007/s00120-010-2424-3  0.04
2010 Mosashvilli D, Kahl P, Mertens C, Holzapfel S, Rogenhofer S, Hauser S, Büttner R, Von Ruecker A, Müller SC, Ellinger J. Global histone acetylation levels: prognostic relevance in patients with renal cell carcinoma. Cancer Science. 101: 2664-9. PMID 20825416 DOI: 10.1111/j.1349-7006.2010.01717.x  0.04
2010 Hauser S, Zahalka T, Ellinger J, Fechner G, Heukamp LC, VON Ruecker A, Müller SC, Bastian PJ. Cell-free circulating DNA: Diagnostic value in patients with renal cell cancer. Anticancer Research. 30: 2785-9. PMID 20683013  0.04
2010 Pölcher M, Ellinger J, Willems S, El-Maarri O, Höller T, Amann C, Wolfgarten M, Rudlowski C, Kuhn W, Braun M. Impact of the menstrual cycle on circulating cell-free DNA. Anticancer Research. 30: 2235-40. PMID 20651374  0.04
2010 Ellinger J, von Rücker A, Bastian PJ, Müller SC. [Circulating cell-free serum DNA: significance as a new biomarker for urological malignancies]. Der Urologe. Ausg. A. 49: 1131-2, 1134. PMID 20628864 DOI: 10.1007/s00120-010-2342-4  0.04
2010 Hauser S, Fechner G, Ellinger J, Müller SC. [Urethral reconstructive surgery]. Der Urologe. Ausg. A. 49: 727-30. PMID 20503034 DOI: 10.1007/s00120-010-2311-y  0.04
2010 Ellinger J, Kahl P, Mertens C, Rogenhofer S, Hauser S, Hartmann W, Bastian PJ, Büttner R, Müller SC, von Ruecker A. Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma. International Journal of Cancer. Journal International Du Cancer. 127: 2360-6. PMID 20162570 DOI: 10.1002/ijc.25250  0.04
2010 Magerl C, Ellinger J, Braunschweig T, Kremmer E, Koch LK, Höller T, Büttner R, Lüscher B, Gütgemann I. H3K4 dimethylation in hepatocellular carcinoma is rare compared with other hepatobiliary and gastrointestinal carcinomas and correlates with expression of the methylase Ash2 and the demethylase LSD1 Human Pathology. 41: 181-189. PMID 19896696 DOI: 10.1016/j.humpath.2009.08.007  0.04
2010 Ellinger J, Kahl P, Von Der Gathen J, Rogenhofer S, Heukamp LC, Gütgemann I, Walter B, Hofstädter F, Büttner R, Müller SC, Bastian PJ, Von Ruecker A. Global levels of histone modifications predict prostate cancer recurrence Prostate. 70: 61-69. PMID 19739128 DOI: 10.1002/pros.21038  0.04
2009 Ellinger J, Albers P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ. CpG Island Hypermethylation of Cell-Free Circulating Serum DNA in Patients With Testicular Cancer Journal of Urology. 182: 324-329. PMID 19447423 DOI: 10.1016/j.juro.2009.02.106  0.04
2009 Ellinger S, Ellinger J, Müller SC, Stehle P. Tomatoes and lycopene in prevention and therapy - Is there an evidence for prostate diseases? | Tomaten und Lykopin in Prävention und Therapie - Gibt es Eine Evidenz bei Prostataerkrankungen? Aktuelle Urologie. 40: 37-43. PMID 19177320 DOI: 10.1055/s-2008-1077031  0.04
2009 Ellinger J, Albers P, Müller SC, Von Ruecker A, Bastian PJ. Circulating mitochondrial DNA in the serum of patients with testicular germ cell cancer as a novel noninvasive diagnostic biomarker Bju International. 104: 48-52. PMID 19154496 DOI: 10.1111/j.1464-410X.2008.08289.x  0.04
2009 Perabo FGE, Von Löw EC, Siener R, Ellinger J, Müller SC, Bastian PJ. A critical assessment of phytotherapy for prostate cancer | Eine kritische bewertung der phytotherapie des prostatakarzinoms Urologe - Ausgabe A. 48: 270-283. PMID 19153707 DOI: 10.1007/s00120-008-1929-5  0.04
2009 Kahl P, Wolf S, Adam A, Heukamp LC, Ellinger J, Vorreuther R, Solleder G, Buettner R. Saturation biopsy improves preoperative Gleason scoring of prostate cancer Pathology Research and Practice. 205: 259-264. PMID 19106019 DOI: 10.1016/j.prp.2008.10.010  0.04
2009 Ellinger J, Wittkamp V, Albers P, Perabo FG, Mueller SC, von Ruecker A, Bastian PJ. Cell-free circulating DNA: diagnostic value in patients with testicular germ cell cancer. The Journal of Urology. 181: 363-71. PMID 19010497 DOI: 10.1016/j.juro.2008.08.118  0.04
2008 Koch LK, Zhou H, Ellinger J, Biermann K, Höller T, von Rücker A, Büttner R, Gütgemann I. Stem cell marker expression in small cell lung carcinoma and developing lung tissue Human Pathology. 39: 1597-1605. PMID 18656241 DOI: 10.1016/j.humpath.2008.03.008  0.04
2008 Ellinger J, Von Rücker A, Wernert N, Büttner R, Bastian PJ, Müller SC. Prostate cancer research: Biomarkers as promising options for optimized diagnosis and treatment | Prostatakarzinomforschung: Biomarker als hoffnung für optimierte diagnostik und therapie Urologe - Ausgabe A. 47: 1190-1192. PMID 18651121 DOI: 10.1007/s00120-008-1833-z  0.04
2008 Bastian PJ, Ellinger J, Von Rücker A, Müller SC, Yegnasubramanian S, Nelson WG, Stief CG. CpG island hypermethylation of the DNA: Perspectives of a molecular biomarker for prostate cancer | CpG-insel-hypermethylierung der DNA: Perspektiven eines molekularen biomarkers für das prostatakarzinom Urologe - Ausgabe A. 47: 1205-1207. PMID 18651120 DOI: 10.1007/s00120-008-1836-9  0.04
2008 Hauser S, Fechner G, Gerhardt T, Klehr HU, Biermann K, Ellinger J, Müller SC. First report of an unexpected blind-ending duplication of the ureter as a rare pitfall in kidney transplantation. Transplant International : Official Journal of the European Society For Organ Transplantation. 21: 696-7. PMID 18435682 DOI: 10.1111/j.1432-2277.2008.00677.x  0.04
2008 Ellinger J, Müller SC, Wernert N, Von Ruecker A, Bastian PJ. Mitochondrial DNA in serum of patients with prostate cancer: A predictor of biochemical recurrence after prostatectomy Bju International. 102: 628-632. PMID 18410441 DOI: 10.1111/j.1464-410X.2008.07613.x  0.04
2008 Ellinger J, Bastian PJ, Ellinger N, Kahl P, Perabo FG, Büttner R, Müller SC, Ruecker Av. Apoptotic DNA fragments in serum of patients with muscle invasive bladder cancer: A prognostic entity Cancer Letters. 264: 274-280. PMID 18329789 DOI: 10.1016/j.canlet.2008.01.038  0.04
2008 Ellinger J, Bastian PJ, Jurgan T, Biermann K, Kahl P, Heukamp LC, Wernert N, Müller SC, von Ruecker A. CpG Island Hypermethylation at Multiple Gene Sites in Diagnosis and Prognosis of Prostate Cancer Urology. 71: 161-167. PMID 18242387 DOI: 10.1016/j.urology.2007.09.056  0.04
2008 Fischer N, Bastian PJ, Ellinger J, Simon A, Bode U, Biermann K, Hadizadeh D, Müller SC. Pediatric renal cell carcinoma. A rare differential diagnosis of Wilms' tumor | Das nierenzellkarzinom beim kind. Eine seltene differenzialdiagnose zum Wilms-tumor Urologe - Ausgabe A. 47: 620-623. PMID 18210066 DOI: 10.1007/s00120-007-1620-2  0.04
2008 Ellinger J, El Kassem N, Heukamp LC, Matthews S, Cubukluoz F, Kahl P, Perabo FG, Müller SC, von Ruecker A, Bastian PJ. Hypermethylation of Cell-Free Serum DNA Indicates Worse Outcome in Patients With Bladder Cancer Journal of Urology. 179: 346-352. PMID 18006010 DOI: 10.1016/j.juro.2007.08.091  0.04
2008 Ellinger J, Haan K, Heukamp LC, Kahl P, Büttner R, Müller SC, Von Ruecker A, Bastian PJ. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer Prostate. 68: 42-49. PMID 18004747 DOI: 10.1002/pros.20651  0.04
2008 Perabo FGE, Von Löw EC, Ellinger J, von Rücker A, Müller SC, Bastian PJ. Soy isoflavone genistein in prevention and treatment of prostate cancer Prostate Cancer and Prostatic Diseases. 11: 6-12. PMID 17923857 DOI: 10.1038/sj.pcan.4501000  0.04
2008 Ellinger J, Bastian PJ, Haan KI, Heukamp LC, Buettner R, Fimmers R, Mueller SC, von Ruecker A. Noncancerous PTGS2 DNA fragments of apoptotic origin in sera of prostate cancer patients qualify as diagnostic and prognostic indicators. International Journal of Cancer. Journal International Du Cancer. 122: 138-43. PMID 17764114 DOI: 10.1002/ijc.23057  0.04
2007 Hauser S, Fisang C, Fechner F, Ellinger J, Haferkamp A, Müller SC. Ureterocystoplasty in the treatment of "low-compliance" bladder in children | Ureteraugmentation der blase bei kindern mit "low-compliance- blase" Urologe - Ausgabe A. 46: 1687-1690. PMID 18071774 DOI: 10.1007/s00120-007-1589-x  0.04
2007 Strunk T, Bastian PJ, Ellinger J, Biermann K, Müller SC. Aggressive course of a malignant alveolar soft tissue sarcoma | Aggressive verlaufsform eines malignen alveolären weichteilsarkoms Urologe - Ausgabe A. 46: 1422-1424. PMID 17641862 DOI: 10.1007/s00120-007-1509-0  0.04
2007 Bastian PJ, Ellinger J, Müller SC, Von Rücker A. Epigenetics of prostate cancer | Epigenetik des prostatakarzinoms: Untersuchung zellulärer informationsträger jenseits der DNA-sequenz Urologe - Ausgabe A. 46: 1080-1081. PMID 17619844 DOI: 10.1007/s00120-007-1433-3  0.04
2007 Ellinger J, Bastian PJ, Biermann K, Schmidt ME, Textor J, Bollmann D, Zhou H, Müller SC. Prostate cancer tissue is masked by bicalutamide: A case report European Journal of Medical Research. 12: 212-215. PMID 17513193  0.04
2007 Bastian PJ, Ellinger J, Heukamp LC, Kahl P, Müller SC, von Rücker A. Prognostic Value of CpG Island Hypermethylation at PTGS2, RAR-beta, EDNRB, and Other Gene Loci in Patients Undergoing Radical Prostatectomy European Urology. 51: 665-674. PMID 16956712 DOI: 10.1016/j.eururo.2006.08.008  0.04
2007 Ellinger S, Ellinger J, Stehle P. Tomatoes, tomato products and lycopene in prevention and therapy of carcinoma of the prostate - What has been verified? | Tomaten, Tomatenprodukte und Lykopin in der Prävention und Therapie des Prostatakarzinoms - Was ist Gesichert? Ernahrungs Umschau. 54: 318-323+307.  0.04
2006 Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R. Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence Cancer Research. 66: 11341-11347. PMID 17145880 DOI: 10.1158/0008-5472.CAN-06-1570  0.04
2006 Brewster L, Brey EM, Addis M, Xue L, Husak V, Ellinger J, Haudenschild CC, Greisler HP. Improving endothelial healing with novel chimeric mitogens. American Journal of Surgery. 192: 589-93. PMID 17071189 DOI: 10.1016/j.amjsurg.2006.08.005  0.04
2006 Ellinger S, Ellinger J, Stehle P. Tomatoes, tomato products and lycopene in the prevention and treatment of prostate cancer: Do we have the evidence from intervention studies? Current Opinion in Clinical Nutrition and Metabolic Care. 9: 722-727. PMID 17053426 DOI: 10.1097/01.mco.0000247470.64532.34  0.04
2006 Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor: Rare, highly aggressive differential diagnosis in urologic malignancies Urology. 68: 257-262. PMID 16904430 DOI: 10.1016/j.urology.2006.02.037  0.04
2006 Ellinger J, Bastian PJ, Hauser S, Biermann K, Müller SC. Primitive neuroectodermal tumor of the kidney | Primitiver neuroektodermaler tumor der niere Urologe - Ausgabe A. 45: 735-738. PMID 16534648 DOI: 10.1007/s00120-006-1029-3  0.04
2005 Bastian PJ, Ellinger J, Wellmann A, Wernert N, Heukamp LC, Müller SC, Von Ruecker A. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci Clinical Cancer Research. 11: 4097-4106. PMID 15930345 DOI: 10.1158/1078-0432.CCR-04-1832  0.04
2004 Bastian PJ, Ellinger J, Schmidt D, Wernert N, Wellmann A, Müller SC, von Rücker A. GSTP1 hypermethylation as a molecular marker in the diagnosis of prostatic cancer: Is there a correlation with clinical stage, gleason grade, PSA value or age? European Journal of Medical Research. 9: 523-527. PMID 15649863  0.04
2004 Laredo J, Xue L, Husak VA, Ellinger J, Singh G, Zamora PO, Greisler HP. Silyl-heparin bonding improves the patency and in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. Journal of Vascular Surgery. 39: 1059-65. PMID 15111862 DOI: 10.1016/j.jvs.2003.12.025  0.04
2003 Laredo J, Xue L, Husak VA, Ellinger J, Greisler HP. Silyl-heparin adsorption improves the in vivo thromboresistance of carbon-coated polytetrafluoroethylene vascular grafts. American Journal of Surgery. 186: 556-60. PMID 14599625 DOI: 10.1016/j.amjsurg.2003.07.015  0.04
2003 Erzurum VZ, Bian JF, Husak VA, Ellinger J, Xue L, Burgess WH, Greisler HP. R136K fibroblast growth factor-1 mutant induces heparin-independent migration of endothelial cells through fibrin glue. Journal of Vascular Surgery. 37: 1075-81. PMID 12756357 DOI: 10.1067/mva.2003.177  0.04
1995 Gosselin C, Ren D, Ellinger J, Greisler HP. In vivo platelet deposition on polytetrafluoroethylene coated with fibrin glue containing fibroblast growth factor 1 and heparin in a canine model The American Journal of Surgery. 170: 126-130. PMID 7543261 DOI: 10.1016/S0002-9610(99)80270-0  0.04
1994 Zenni GC, Ellinger J, Lam TM, Greisler HP. Biomaterial-induced macrophage activation and monokine release Journal of Investigative Surgery. 7: 135-141. PMID 8049176 DOI: 10.3109/08941939409015357  0.04
1993 Greisler HP, Petsikas D, Lam TM, Patel N, Ellinger J, Cabusao E, Tattersall CW, Kim DU. Kinetics of cell proliferation as a function of vascular graft material Journal of Biomedical Materials Research. 27: 955-961. PMID 8360222  0.04
1991 Greisler HP, Ellinger J, Henderson SC, Shaheen AM, Burgess WH, Kim DU, Lam TM. The effects of an atherogenic diet on macrophage/biomaterial interactions. Journal of Vascular Surgery. 14: 10-23. PMID 1829487 DOI: 10.1016/0741-5214(91)90149-O  0.04
1990 Greisler HP, McGurrin JF, Klosak JJ, Tattersall CW, Ellinger J, Henderson SC, Cabusao EA. The validity of canine platelet aggregometry in predicting vascular graft patency Journal of Cardiovascular Surgery. 31: 712-718. PMID 2262494  0.04
1990 Greisler HP, Klosak JJ, McGurrin JF, Endean ED, Ellinger J, Pozar JD, Henderson SC, Kim DU. Prostacyclin production by blood-contacting surfaces of endothelialized vascular prostheses Journal of Cardiovascular Surgery. 31: 640-645. PMID 2146273  0.04
1989 Greisler HP, Endean ED, Klosak JJ, Ellinger J, Henderson SC, Pham M, Durham SJ, Showalter DP, Levine J, Borovetz HS. Hemodynamic Effects on Endothelial Cell Monolayer Detachment From Vascular Prostheses Archives of Surgery. 124: 429-433. PMID 2930352 DOI: 10.1001/archsurg.1989.01410040039008  0.04
1989 Greisler HP, Klosak JJ, Steinam S, Burgess WH, Henders on SC, Cabusao EA, Ellinger J. Platelet interactions with heparin binding growth factor and fibronectin Asaio Transactions. 35: 561-563. PMID 2597534  0.04
1989 Greisler HP, Dennis JW, Schwarcz TH, Klosak JJ, Ellinger J, Kim D. Plasma Polymerized Tetrafluoroethylene/Polyethylene Terephthalate Vascular Prostheses Archives of Surgery. 124: 967-972. PMID 2527022 DOI: 10.1001/archsurg.1989.01410080103017  0.04
1989 Greisler HP, Dennis JW, Endean ED, Ellinger J, Friesel R, Burgess W. Macrophage/biomaterial interactions: The stimulation of endothelialization Journal of Vascular Surgery. 9: 588-593. PMID 2523491 DOI: 10.1016/0741-5214(89)90478-3  0.04
1988 Greisler HP, Endean ED, Klosak JJ, Ellinger J, Dennis JW, Buttle K, Un Kim D. Polyglactin 910/ polydioxanone bicomponent totally resorbable vascular prostheses Journal of Vascular Surgery. 7: 697-705. PMID 3130496 DOI: 10.1016/0741-5214(88)90016-X  0.04
1988 Greisler HP, Dennis JW, Endean ED, Ellinger J, Buttle KF, Kim DU. Derivation of neointima in vascular grafts Circulation. 78: I-6-I-12. PMID 2970347  0.04
1987 Schwarcz TH, Nussbaum ML, Ellinger J, Kim DU, Greisler HP. Prostaglandin content of tissue lining vascular prostheses Current Surgery. 44: 18-21. PMID 3829709  0.04
1987 Greisler HP, Kim DU, Dennis JW, Klosak JJ, Widerborg KA, Endean ED, Raymond RM, Ellinger J. Compound polyglactin 910/polypropylene small vessel prostheses Journal of Vascular Surgery. 5: 572-583. PMID 3550160 DOI: 10.1016/0741-5214(87)90223-0  0.04
1987 Greisler HP, Ellinger J, Schwarcz TH, Golan J, Raymond RM, Kim D. Arterial Regeneration Over Polydioxanone Prostheses in the Rabbit Archives of Surgery. 122: 715-721. PMID 3107517 DOI: 10.1001/archsurg.1987.01400180097019  0.04
1987 Greisler HP, Klosak JJ, Dennis JW, Karesh SM, Ellinger J, Kim DU. Biomaterial pretreatment with ECGF to augment endothelial cell proliferation Journal of Vascular Surgery. 5: 393-402. PMID 2950245 DOI: 10.1016/0741-5214(87)90151-0  0.04
1986 Greisler HP, Klosak J, Dennis JW, Ellinger J, Un Kim D, Burgess W, Maciag T. Endothelial cell growth factor attachment to biomaterials. Asaio Transactions / American Society For Artificial Internal Organs. 32: 346-9. PMID 3535846  0.04
1986 Greisler HP, Schwarcz TH, Ellinger J, Kim DU. Dacron inhibition of arterial regenerative activities Journal of Vascular Surgery. 3: 747-756. PMID 3009903 DOI: 10.1016/0741-5214(86)90039-X  0.04
1986 Schwarcz TH, Nussbaum ML, Ellinger J, Greisler HP. Inner capsule prostaglandin content of vascular prostheses Surgical Forum. 37: 441-442.  0.04
1985 Greisler HP, Fareed J, Ellinger J. Inhibition of arterial regeneration by dacron Federation Proceedings. 44: No. 224.  0.04
2015 Sakai Y, Abe K, Nakashima S, Ellinger JJ, Ferri S, Sode K, Ikebukuro K. Scaffold-fused riboregulators for enhanced gene activation in Synechocystis sp. PCC 6803. Microbiologyopen. PMID 25865486 DOI: 10.1002/mbo3.257  0.01
2013 Du J, Bittner F, Hecht DS, Ladous C, Ellinger J, Oekermann T, Wark M. A carbon nanotube-based transparent conductive substrate for flexible ZnO dye-sensitized solar cells Thin Solid Films. 531: 391-397. DOI: 10.1016/j.tsf.2012.12.051  0.01
2008 Brumovsky M, Brynda J, Ellinger J. Welding repair procedure of defects in WWER reactor pressure vessels American Society of Mechanical Engineers, Pressure Vessels and Piping Division (Publication) Pvp. 6: 907-911. DOI: 10.1115/PVP2007-26324  0.01
1999 Anderson P, Russell B, Ellinger J. An insider's view of three nursing specialties. Interview by Susan Trossman The American Nurse. 31: 1-2. PMID 2000137078  0.01
1998 Ellinger J. The little engine that could and slowly will: a bureaucrat's view Frontiers of Health Services Management. 14: 27-30; discussion 41. PMID 10181815  0.01
1983 Cole MB, Narine KR, Ellinger J. Morphological evidence of the shedding of chondrocytes from the articular surface in neonatal rats: Relationship to the interlacunar network Anatomical Record. 206: 439-446. PMID 6625202  0.01
1981 Cole MB, Ellinger J. Glycol methacrylate in light microscopy: Nucleic acid cytochemistry Journal of Microscopy. 123: 75-88. PMID 6167720  0.01
1977 Ellinger J. Adult orthodontics with removable appliances Journal (Anglo-Continental Dental Society). 12-18. PMID 281161  0.01
1976 Abraira C, Ellinger J. Modifications of metabolic adaptations to fasting by low dose oral glucose Clinical Research. 24: 355A.  0.01
1966 Vaught GM, Ellinger J. Field-dependence and form discrimination Psychonomic Science. 6: 357-358. DOI: 10.3758/BF03330935  0.01
1934 Ellinger J. Über die mit that zusammengesetzten bindewörter im neueren englisch Anglia. 1934: 410-444. DOI: 10.1515/angl.1934.1934.58.410  0.01
1933 Ellinger J. Substantivsätze mit oder ohne that in der neueren englischen literatur Anglia. 1933: 78-109. DOI: 10.1515/angl.1933.1933.57.78  0.01
1910 Ellinger J. Gerundium, infinitiv und that-satz als adverbale oder adnominale ergänzung Anglia. 1910: 480-522. DOI: 10.1515/angl.1910.1910.33.480  0.01
Hide low-probability matches.